Sort
34,240 grants matching “atherosclerosis”
1/2 REPRIEVE Extension for Trial Completion
$2,903,944Steven Kyle Grinspoon · Massachusetts General Hospital · UG3 · FY2025 · HL
Brain atrophy, cognitive impairment, and Alzheimer's in a low CVD-risk population
$2,902,118Hillard S Kaplan · Chapman University · RF1 · FY2018 · AG
Comparative Approach to Genomics of Complex Traits
$2,900,943William E Kraus · Duke University · P01 · FY2006 · HL
Genome-wide Search for CVD Gene-Environment Interactions
$2,897,961University Of Maryland Baltimore · U01 · FY2004 · HL
Remote Monitoring and Virtual Collaborative Care for Hypertension Control to Prevent Cognitive Decline
$2,894,445Aditi Gupta · University Of Kansas Medical Center · R33 · FY2023 · AG
Lupus Clinical Trials
$2,893,174Sarfaraz Hasni · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2023 · AR
Long Life Family Study: Data Management and Coordinating Center
$2,887,696Michael A Province · Washington University · U01 · FY2016 · AG
Remote Monitoring and Virtual Collaborative Care for Hypertension Control to Prevent Cognitive Decline
$2,887,685Aditi Gupta · University Of Kansas Medical Center · R33 · FY2024 · AG
Testing Hypothesized Pathways Linking Infection, Physical Activity, Apoe Genotype, And Biological Sex To Low Dementia Prevalence And Reduced Brain Atrophy In Two Native American Populations
$2,883,093Hillard S Kaplan · Chapman University · R01 · FY2025 · AG
DIET AND GENOTYPE IN PRIMATE ATHEROSCLEROSIS
$2,881,311Southwest Foundation For Biomedical Res · P01 · FY2003 · HL
Chemical Receptor Interactions In Reproduction And Hormonal Toxicity
$2,878,241Kenneth S Korach · Environmental Health Sciences · Z01 · FY2007 · ES
Framingham Project/Levy
$2,869,590Daniel Levy · National Heart, Lung, And Blood Institute · ZIA · FY2010 · HL
Three-Dimensional Cell and Tissue Reconstruction by Serial Block Face SEM
$2,869,479Richard Leapman · National Institute Of Biomedical Imaging And Bioengineering · ZIA · FY2023 · EB
OPTION PERIOD ONE (1): TASK AREA B.2. - COHORT EXAM 4 AND EXAM CLOSEOUT FOR JACKSON HEART STUDY (JHS) COORDINATING CENTER (CC).
$2,868,729April P Carson · University Of Mississippi Med Ctr · N01 · FY2023 · HL
Comparison of Anti-coagulation and anti-Platelet Therapies for Intracranial Vascular Atherostenosis
$2,862,143Brian Lim Hoh · University Of Florida · U01 · FY2024 · NS
MESA
$2,860,530Steven J Shea · Columbia Univ New York Morningside · N01 · FY2009 · HL
Lupus Clinical Trials
$2,858,919Sarfaraz Hasni · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2022 · AR
DIET AND GENOTYPE IN PRIMATE ATHEROSCLEROSIS
$2,857,400Southwest Foundation For Biomedical Res · P01 · FY2004 · HL
Pharmacogenomics and Risk of Cardiovascular Disease
$2,850,491Ronald M Krauss · Children'S Hospital & Res Ctr At Oakland · U01 · FY2008 · HL
Mass Spectrometry Resource for Biology and Medicine
$2,846,209Catherine E. Costello · Boston University Medical Campus · P41 · FY2012 · GM
Biological and mechanical therapies enabled by cardiovascular interventional MRI
$2,844,293Robert J Lederman · National Heart, Lung, And Blood Institute · Z01 · FY2008 · HL
Comparative Approach to Genomics of Complex Traits
$2,843,468Duke University · P01 · FY2005 · HL
Aging, Cognition, and Hearing Evaluation in Elders (ACHIEVE) Randomized Trial
$2,841,558Frank R Lin · Johns Hopkins University · R01 · FY2020 · AG
Atherosclerosis Intervention with Novel Tissue Selective Estrogen Complex Therapy
$2,837,871Howard N Hodis · University Of Southern California · R01 · FY2021 · AG
Task Area A Core Study Operations.Task Area A shall encompass annual follow-up of cohort members, clinical endpoints ascertainment, study coordination activities, maintenance of the database and biosp
$2,834,798Robyn McClelland · University Of Washington · N01 · FY2024 · HL